Clinical Trials on Dual-target CAR-T Cells
Total 3113 results
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States, Canada
-
TakedaCompletedHodgkin Disease | Lymphoma, Large-cell, AnaplasticRussian Federation
-
European Inter-group Cooperation on Childhood and...UnknownLymphomaFrance, United Kingdom, Germany, Italy, Belgium, Switzerland, Austria, Czech Republic, Ireland, Netherlands, Poland, Sweden
-
Gustave Roussy, Cancer Campus, Grand ParisCompletedLymphomaFrance, Spain, Italy, Belgium, Germany, Switzerland, Austria, United Kingdom, Netherlands, Sweden
-
Jiangsu Simcere Biologics Co., LtdRecruitingAdvanced Solid Tumor | Cutaneous T Cell LymphomaChina
-
Rong TaoRecruitingNatural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
Cancer Institute and Hospital, Chinese Academy...UnknownNatural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
National Cancer Institute (NCI)Completed
-
Acrotech Biopharma Inc.Axis Clinicals LimitedCompletedRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaUnited States
-
China Medical University HospitalCompletedIL-17+ CD8 T Cells in Cancer PatientsTaiwan
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingRecurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Recurrent... and other conditionsUnited States
-
University College, LondonMerck Sharp & Dohme LLCActive, not recruitingCutaneous T Cell Lymphoma | Mycosis Fungoides/Sezary SyndromeUnited Kingdom
-
European Organisation for Research and Treatment...TerminatedEarly Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB)France
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage III Multiple Myeloma | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma and other conditionsUnited States
-
Shanghai YingLi Pharmaceutical Co. Ltd.RecruitingPeripheral T/NK Cell Lymphoma (R/R PTCL)United States
-
Xinqiao Hospital of ChongqingThe First Affiliated Hospital of Anhui Medical University; Nanfang Hospital... and other collaboratorsRecruitingT-cell Lymphoma | T-cell LeukemiaChina
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Terminated
-
Asana BioSciencesTerminatedLymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Cancer | Lymphoma, Malignant | Myelofibrosis | Lymphoma, Mantle-Cell | Chronic Lymphocytic Leukemia | Peripheral T-Cell Lymphoma | Tumor | Neoplasm | B-Cell Chronic Lymphocytic Leukemia | Leukemia, Lymphocytic, Chronic | Idiopathic Myelofibrosis and other conditionsUnited States, Argentina
-
Polish Lymphoma Research GroupTerminatedLymphoma, T-Cell, Cutaneous | Mycosis FungoidesPoland
-
Mundipharma Research LimitedInnovative Therapies For Children with Cancer ConsortiumTerminatedRelapsed or Refractory T-cell Acute Lymphoblastic Leukaemia | B-cell Precursor Acute Lymphoblastic Leukaemia | T-cell Non-Hodgkin's LymphomaCzech Republic, Austria, France, Germany, Italy, United Kingdom
-
Fundació Institut de Recerca de l'Hospital de la...Instituto de Salud Carlos III; Josep Carreras Leukaemia Research InstituteRecruitingHodgkin Lymphoma, Adult | T Cell LymphomaSpain
-
University of ArizonaNational Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Anaplastic Large Cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Anaplastic Large Cell LymphomaUnited States
-
Institute of Hematology & Blood Diseases HospitalThe First Affiliated Hospital of Nanchang University; Henan Cancer Hospital; The... and other collaboratorsRecruiting
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma | Aggressive Non-Hodgkin... and other conditionsUnited States
-
Novartis PharmaceuticalsUniversity of PennsylvaniaRecruitingLong Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access ProgramUnited States, Japan, Australia, Germany, Spain, Belgium, Taiwan, Italy, Canada, Israel, Singapore, United Kingdom, Denmark, Finland, Norway, Austria, Netherlands, France
-
NYU Langone HealthTerminatedCutaneous T Cell LymphomaUnited States
-
University College, LondonCompleted
-
Huiqiang HuangRecruitingDiffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Transformed Lymphoma | EBV-Positive DLBCL, Nos | ALK-Positive Anaplastic Large Cell Lymphoma | Follicular Lymphoma Grade IIIbChina
-
Yale UniversityKyowa Kirin, Inc.Not yet recruitingT Cell LymphomaUnited States
-
Huiqiang HuangRecruitingDiffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Transformed Lymphoma | EBV-Positive DLBCL, Nos | ALK-Positive Anaplastic Large Cell Lymphoma | Follicular Lymphoma Grade IIIbChina
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell... and other conditionsUnited States, Italy
-
TakedaCompletedHodgkin Disease | Lymphoma, Large-Cell, AnaplasticChina
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma and other conditionsUnited States
-
Arvinas Inc.RecruitingRelapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL) | Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL)United States, Spain
-
Merck Sharp & Dohme LLCCompleted
-
Shenzhen Fifth People's HospitalRecruiting
-
Stanford UniversityNational Institutes of Health (NIH); AmgenCompletedLymphoma, Non-Hodgkin | Lymphomas: Non-Hodgkin | Lymphomas: Non-Hodgkin Peripheral T-Cell | Lymphomas: Non-Hodgkin Cutaneous Lymphoma | Lymphomas: Non-Hodgkin Diffuse Large B-Cell | Lymphomas: Non-Hodgkin Follicular / Indolent B-Cell | Lymphomas: Non-Hodgkin Mantle Cell | Lymphomas: Non-Hodgkin Marginal... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedAlisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell LymphomasRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With... and other conditionsUnited States
-
Second Affiliated Hospital of Guangzhou Medical...Hunan Zhaotai Yongren Medical Innovation Co. Ltd.RecruitingAnti-cancer Cell Immunotherapy | T Cell and NK CellChina
-
TakedaWithdrawnSolid Tumors | Anaplastic Lymphoma Kinase Positive (ALK +) Anaplastic Large Cell Lymphoma | Inflammatory Myofibroblastic Tumors
-
CRISPR Therapeutics AGActive, not recruitingT Cell LymphomaUnited States, Australia, Canada
-
Aptevo TherapeuticsTerminatedChronic Lymphocytic Leukemia | Peripheral T-cell LymphomaUnited States
-
Helsinn Therapeutics (U.S.), IncCompleted
-
National Cancer Institute (NCI)TerminatedRecurrent Cutaneous T-cell Non-Hodgkin Lymphoma | Recurrent Mycosis Fungoides/Sezary SyndromeUnited States
-
Princess Maxima Center for Pediatric OncologyTakedaRecruitingAnaplastic Large Cell Lymphoma, ALK-Positive | Inflammatory Myofibroblastic Tumor | Other Solid TumorFrance, Netherlands
-
Mundipharma Research LimitedActive, not recruitingMultiple Myeloma | Hodgkin's Lymphoma | Hematological Malignancies | Cutaneous T Cell LymphomaFrance, United States, Netherlands, Spain, Switzerland, Germany, Italy
-
M.D. Anderson Cancer CenterActive, not recruitingRecurrent T-Cell Prolymphocytic Leukemia | T-Cell Prolymphocytic LeukemiaUnited States
-
Rochester Skin Lymphoma Medical Group, PLLCRochester General HospitalCompletedMycosis Fungoides | Cutaneous T-cell Lymphoma | Transformed Mycosis Fungoides | Cutaneous T-cell Lymphoma Stage I | Folliculotropic Mycosis Fungoides | Granulomatous Slack Skin | Syringotropic Mycosis Fungoides | Mycosis Fungoides VariantUnited States
-
Chonnam National University HospitalBayer; Consortium for Improving Survival of LymphomaCompletedMature T-Cell and NK-Cell NeoplasmKorea, Republic of